COMPANY
AVITA Medical
FDA-cleared device company Past trials only
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| International Clinical Training Specialist - Europe | Field - International, Remote | Oct 7, 2026 | Oct 16, 2026 |
| Independent Contract Sales Representative (1099) – Hawaii | Hawaii, Remote | Jul 9, 2026 | Oct 16, 2026 |
Timeline
- Debt Debt: $17.6M (not counted as a raise), announced Jan 13, 2026. Source: SEC filing. source ↗
- Trial start Not phased (device or behavioral study): Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyx™ is Used for Full Thickness Wounds source ↗
- Trial start Not phased (device or behavioral study): Randomized Controlled Trial to Investigate Clinical Outcomes and Associated Costs When PermeaDerm is Used as Temporary Dressing for Surgical Wounds source ↗
- Trial start Not phased (device or behavioral study): Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells source ↗
- Trial start Not phased (device or behavioral study): Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions source ↗
- Trial start Not phased (device or behavioral study): Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions source ↗
- Trial start Not phased (device or behavioral study): RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years source ↗
- Trial start Not phased (device or behavioral study): RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction source ↗
- Trial start Not phased (device or behavioral study): RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years source ↗
- Trial start —: Continued Access to the Recell® Device for Treatment of Acute Burn Injuries source ↗
- Trial start Not phased (device or behavioral study): CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries source ↗
- Trial start Phase 4: A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers source ↗
- Trial start Not phased (device or behavioral study): ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries source ↗
- Trial start —: Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases source ↗
- Trial start Phase 4: A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers source ↗
- Trial start Not phased (device or behavioral study): A Multicenter Comparative Study of the ReCell Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries source ↗
Funding
- Debt: $17.6M (not counted as a raise), announced Jan 13, 2026. Source: SEC filing. source ↗
Clinical trials (lead sponsor) 15
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06750809 | Randomized Controlled Trial to Investigate Clinical Outcomes and Associated Costs When PermeaDerm is Used as Temporary Dressing for Surgical Wounds | Not phased (device or behavioral study) | Completed | Feb 21, 2025 | Mar 18, 2026 (actual) |
| NCT06787690 | Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyx™ is Used for Full Thickness Wounds | Not phased (device or behavioral study) | Completed | May 15, 2025 | Feb 10, 2026 (actual) |
| NCT05971381 | Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells | Not phased (device or behavioral study) | Completed | Aug 14, 2023 | Jul 30, 2024 (actual) |
| NCT02380612 | ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries | Not phased (device or behavioral study) | Completed | Jan 26, 2015 | Jan 21, 2016 (actual) |
| NCT04091672 | RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction | Not phased (device or behavioral study) | Completed | Mar 2, 2020 | Mar 7, 2022 (actual) |
| NCT03333941 | Continued Access to the Recell® Device for Treatment of Acute Burn Injuries | Not listed | Completed | Oct 26, 2017 | Dec 19, 2018 (actual) |
| NCT02994654 | CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries | Not phased (device or behavioral study) | Completed | 2016-10 | 2017-12 (actual) |
| NCT03626701 | RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years | Not phased (device or behavioral study) | Terminated | Mar 3, 2020 | Jun 23, 2021 (actual) |
| NCT03624192 | RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years | Not phased (device or behavioral study) | Terminated | Sep 19, 2018 | Jan 13, 2020 (actual) |
| NCT04547998 | Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions | Not phased (device or behavioral study) | Completed | Sep 10, 2020 | Jun 28, 2022 (actual) |
| NCT04271501 | Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions | Not phased (device or behavioral study) | Terminated | Sep 25, 2020 | Aug 24, 2021 (actual) |
| NCT02992249 | Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases | Not listed | Completed | 2014-05 | 2019-05 (actual) |
| NCT02799121 | A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers | Phase 4 | Completed | 2016-05 | Mar 29, 2019 (actual) |
| NCT01138917 | A Multicenter Comparative Study of the ReCell Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries | Not phased (device or behavioral study) | Completed | May 21, 2010 | Aug 29, 2014 (actual) |
| NCT01743053 | A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers | Phase 4 | Completed | 2013-01 | 2015-10 (actual) |
Open jobs 2
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| International Clinical Training Specialist - Europe | Field - International, Remote | Oct 7, 2026 | Oct 16, 2026 | Not stated |
| Independent Contract Sales Representative (1099) – Hawaii | Hawaii, Remote | Jul 9, 2026 | Oct 16, 2026 | Mid |
Connect
See your connections at AVITA Medical on LinkedIn (search by name, results not checked)